Literature DB >> 17479771

Early dexamethasone treatment after implantation of a sciatic-nerve cuff decreases the concentration of substance P in the lumbar spinal cord of rats with neuropathic pain.

Francis Beaudry1, Christiane Girard, Pascal Vachon.   

Abstract

The main purpose of this study was to evaluate the effects of early dexamethasone treatment on pain-related peptides at an early stage in the development of neuropathic pain induced by implantation of a sciatic nerve cuff in Sprague Dawley rats (body weight 250 to 350 g). The rats were tested for touch sensitivity with the use of von Frey filaments before and 3 d after cuff implantation (n = 12) or sham surgery (n = 6). Half of the cuff-implanted rats received dexamethasone, 1 mg/kg intraperitoneally, 1 h after surgery. Spinal cords were collected on the 3rd day after surgery, and the lumbar enlargement was processed for the detection of selected peptides (neurotensin, substance P, cholecystokinin [CCK], vasoactive intestinal peptide, and calcitonin gene-related peptide) by means of liquid chromatography and tandem mass spectrometry. The right sciatic nerve of each rat was collected, fixed, and stained for histopathological evaluation. Except for neurotensin, all the peptides showed an increased concentration with neuropathic pain; however, the differences were significant (P < 0.05) only for substance P and CCK. In the animals treated with dexamethasone, mechanical allodynia was less pronounced (P < 0.01), and only the concentration of substance P was decreased significantly (P < 0.05). Sciatic nerve sections showed a decrease in C (P < 0.01) and Adelta (P < 0.03) fibres with neuropathic pain and a nearly normal percentage of C fibres after dexamethasone treatment. The dexamethasone-treated animals also had less inflammation detectable microscopically at the nerve constriction site compared with cuff-implanted animals that were not treated with dexamethasone. Our results suggest that in the early stages of neuropathic pain induced by an inflammatory process, dexamethasone may be a useful treatment and that substance P plays an important role in pain perception.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479771      PMCID: PMC1829183     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  29 in total

Review 1.  Mechanisms of neuropathic pain.

Authors:  D Bridges; S W Thompson; A S Rice
Journal:  Br J Anaesth       Date:  2001-07       Impact factor: 9.166

2.  Effect of local methylprednisolone on pain in a nerve injury model. A pilot study.

Authors:  A Johansson; G J Bennett
Journal:  Reg Anesth       Date:  1997 Jan-Feb

3.  Nerve constriction in the rat: model of neuropathic, surgical and central pain.

Authors:  G M Pitcher; J Ritchie; J L Henry
Journal:  Pain       Date:  1999-10       Impact factor: 6.961

4.  Methylprednisolone prevents the development of autotomy and neuropathic edema in rats, but has no effect on nociceptive thresholds.

Authors:  W S Kingery; J M Castellote; M Maze
Journal:  Pain       Date:  1999-04       Impact factor: 6.961

5.  Spared nerve injury: an animal model of persistent peripheral neuropathic pain.

Authors:  Isabelle Decosterd; Clifford J Woolf
Journal:  Pain       Date:  2000-08       Impact factor: 6.961

6.  Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain.

Authors:  J-S Walczak; V Pichette; F Leblond; K Desbiens; P Beaulieu
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

7.  Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury.

Authors:  Shuxing Wang; Grewo Lim; Qing Zeng; Backil Sung; Liling Yang; Jianren Mao
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

8.  Effect of methylprednisolone on neuropathic pain and spinal glial activation in rats.

Authors:  Kenji Takeda; Shigehito Sawamura; Hiroshi Sekiyama; Hisayoshi Tamai; Kazuo Hanaoka
Journal:  Anesthesiology       Date:  2004-05       Impact factor: 7.892

9.  Pharmacological sensitivity and gene expression analysis of the tibial nerve injury model of neuropathic pain.

Authors:  Heiko A Hofmann; Jean De Vry; Angela Siegling; Peter Spreyer; Dirk Denzer
Journal:  Eur J Pharmacol       Date:  2003-05-30       Impact factor: 4.432

10.  Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain.

Authors:  A L Clatworthy; P A Illich; G A Castro; E T Walters
Journal:  Neurosci Lett       Date:  1995-01-16       Impact factor: 3.046

View more
  4 in total

1.  Activation of GRs-Akt-nNOs-NR2B signaling pathway by second dose GR agonist contributes to exacerbated hyperalgesia in a rat model of radicular pain.

Authors:  Jing Zhang; Wei Zhang; Yu'e Sun; Yue Liu; Lihua Song; Zhengliang Ma; Xiaoping Gu
Journal:  Mol Biol Rep       Date:  2014-02-23       Impact factor: 2.316

2.  Intrathecal Administration of Tempol Reduces Chronic Constriction Injury-Induced Neuropathic Pain in Rats by Increasing SOD Activity and Inhibiting NGF Expression.

Authors:  Baisong Zhao; Yongying Pan; Zixin Wang; Yonghong Tan; Xingrong Song
Journal:  Cell Mol Neurobiol       Date:  2015-10-03       Impact factor: 5.046

3.  Mass Spectrometry in Pharmacokinetic Studies of a Synthetic Compound for Spinal Cord Injury Treatment.

Authors:  María Sánchez-Sierra; Isabel García-Álvarez; Alfonso Fernández-Mayoralas; Sandra Moreno-Lillo; Gemma Barroso García; Verónica Moral Dardé; Ernesto Doncel-Pérez
Journal:  Biomed Res Int       Date:  2015-05-19       Impact factor: 3.411

4.  The sciatic nerve cuffing model of neuropathic pain in mice.

Authors:  Ipek Yalcin; Salim Megat; Florent Barthas; Elisabeth Waltisperger; Mélanie Kremer; Eric Salvat; Michel Barrot
Journal:  J Vis Exp       Date:  2014-07-16       Impact factor: 1.355

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.